Response Evaluation as the Key-point in Results Interpretation

Balducci L. , Mowrey K. , Parker M. : Pharmacology of antineoplastic agents in older patients, In: Geriatric oncology, Balducci L. , Lyman G.H. , Ershler V.B. (Eds.), pp. 165–180, Philadelphia, Lippincott, 1992.

Buroker T.R. , O'Connell M.J. , Wieand H.S. , Kroof J.E. , Gerstne J.R. , Maillard J.A. , Schaefer P.L. , Levitt R. , Kardinal C.G. , Gesme D.H. : Randomized comparison of two schedules of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J. Clin. Oncol., 12: 14–20, 1994.

Buyse M. , Piedbois P. : Meta-analysis, use and misuse. J. Clin. Oncol., 11: 382, 1993.

Chalmers T.C. , Lau J. : Meta-analysis of randomized control trials applied to cancer therapy. In: Important advances in oncology, De Vita V.T. , Hellman S. , Rosenberg S.A. (Eds.), pp. 235–241, Philadelphia, Lippincott, 1992.

Gennari L. , Doci R. , Bozzetti E. : Proposal for a clinical classification of liver metastases. Tumori, 68: 443–449, 1982.

Glimelius B. , Hoffman K. , Graf W. : Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer, 73: 556–562, 1994.

Graf W. , Glimelius B. , Pahlman L.J. : Determinants of prognosis in advanced colorectal cancer. Eur. J. Can., 9: 1119–1123, 1991.

Kemeny N. , Braun D.W. : Prognostic factors in advanced colorectal carcinoma. The importance of lactic dehydrogenase, performance status and white blood cells count. Am. J., Med., 74: 786–794, 1983.

Michels K.B. : Quo vadis meta-analysis? A potentially dangerous tool if used without adequate rules. In: Important advances in oncology, De Vita V.T. , Hellman S. , Rosenberg S.A. (Eds.), pp. 243–248, Philadelphia, Lippincott, 1992.

Miller A.B. , Hoogstraten B. , Staquet M. : Reporting results of cancer treatment. Cancer, 47: 207–214, 1981.

Moertel C.G. , Hanley J.A. : The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer, 38: 388–394, 1976.

Niederhuber J.E. , Ensminger W.D. : Treatment of metastatic cancer to the liver. In: Cancer: principles and practice of oncology. De Vita V.T. , Hellman S. , Rosenberg S.A. (Eds.), pp. 2201–2225, Philadelphia, Lippincott, 1993.

Poon M.A. , O'Connell M.J. , Moertel C.G. : Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J. Clin. Oncol., 7: 1407–1417, 1989.

Poon M.A. , O'Connell M.J. , Wieand H.S. : Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J. Clin. Oncol., 9: 1967–1972, 1991.

Simon R. : Design and conduct of clinical trials. In: Cancer: Principles and practice of oncology, De Vita V.T. , Hellman S. , Rosenberg S.A. (Eds.), pp. 418–440, Philadelphia, Lippincott, 1993.

UICC: Clinical oncology, pp. 112–115, 1987.

Warr D. , McKinney S. , Tannock I. : Influence of measurement error on assessment of response to anticancer chemotherapy. Proposal for new criteria of tumor response. J. Clin. Oncol., 2: 1040–1046, 1984.